CStone Pharmaceuticals
CSPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,105,125 | $2,877,579 | $4,777,811 | $9,165,980 |
| - Cash | $387,937 | $996,671 | $558,684 | $742,724 |
| + Debt | $355,973 | $363,448 | $286,290 | $174,198 |
| Enterprise Value | $2,073,161 | $2,244,356 | $4,505,417 | $8,597,454 |
| Revenue | $407,205 | $463,842 | $481,363 | $243,718 |
| % Growth | -12.2% | -3.6% | 97.5% | – |
| Gross Profit | $240,154 | $304,295 | $278,378 | $136,886 |
| % Margin | 59% | 65.6% | 57.8% | 56.2% |
| EBITDA | -$26,235 | -$297,225 | -$849,661 | -$1,895,197 |
| % Margin | -6.4% | -64.1% | -176.5% | -777.6% |
| Net Income | -$91,207 | -$367,234 | -$902,678 | -$1,920,100 |
| % Margin | -22.4% | -79.2% | -187.5% | -787.8% |
| EPS Diluted | -0.072 | -0.29 | -0.77 | -1.65 |
| % Growth | 75.3% | 62.3% | 53.3% | – |
| Operating Cash Flow | -$343,181 | -$588,843 | -$612,469 | -$1,484,024 |
| Capital Expenditures | $0 | -$65,047 | -$101,821 | -$149,136 |
| Free Cash Flow | -$343,181 | -$653,890 | -$714,290 | -$1,633,160 |